Dexcom (DXCM) and Abbott are set to launch their first FDA-approved over-the-counter CGMs, Stelo and Lingo & Libre Rio, respectively, in the United States this summer.
These stocks have excellent track records of beating the market.
Smart rings and smartwatches are providing consumers with reams of health information. Clinical device makers like DexCom needn’t worry.